China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL

China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL

Innovative drugs VALTOCO (Diazepam Nasal Spray),ILUMETRI (Tildrakizumab Injection) and rare disease drug Tetrabenazine Tablets have been newly included in China’s National Reimbursement Drug List(NRDL), XinHuoSu (Recombinant Human Brain Natriuretic Peptide for Injection) has continued to be included in NRDL.- China Medical System actively responds to national policies to promote innovative products to be included in the NRDL…
Read More

Zaļā Josta - Reklāma